Prime Doctor RX review

Prime Doctor RX does something this category rarely does: every pricing card carries the prepay rate, the month-to-month rate and a footnote saying which is which. Semaglutide is $179/month at 52 weeks and $249 month-to-month, and both numbers sit on the same card. That candor is worth a lot in a category where the norm is to show only the lower figure. Two things temper it. The month-to-month price bills every four weeks, which is thirteen charges a year rather than twelve, so $249 is nearer $270 a month — arithmetic the site doesn't do for you. And for a service that leads on transparency, it names neither the pharmacy nor the medical group.

A telehealth service with two declared care paths — medical weight loss and hormone care — describing itself as veteran and firefighter owned. Weight loss covers compounded semaglutide injection, compounded tirzepatide injection and oral semaglutide. Hormone care covers injectable and topical testosterone plus enclomiphene, with NAD⁺ and sermorelin mentioned as add-ons when clinically appropriate. Intake runs through OpenLoop Health and the patient portal through Tellescope.

Choose an intake, complete labs if ordered, get a clinician decision. Hormone care is the stricter path and the site is clear about it: initial hormone-care labs are $50, lab requirements depend on history and clinician judgment, and "medication is never guaranteed just because you complete an intake." Both async and sync visits are offered depending on the program. For a service whose pitch is transparency, the operational disclosure is thin: no pharmacy is named, no medical group is named, no state list is published, and there is no LegitScript reference anywhere on the site. The NAD⁺ and sermorelin "add-ons" appear in one line of hormone-care copy with no product page and no price, which is why we don't cover it as a peptide or NAD⁺ provider.

Unusually complete pricing, and the kind that still needs arithmetic. Semaglutide injection: $249 month-to-month, or $657 for 12 weeks ($219/mo), $1,194 for 24 weeks ($199/mo), $2,327 for 52 weeks ($179/mo). Tirzepatide injection: $339 month-to-month, $927 / $1,734 / $3,497 ($309, $289, $269). Oral semaglutide: $279 month-to-month, $777 / $1,434 / $2,717 ($259, $239, $209). TRT is advertised from $119/mo on the same structure. Every card states the month-to-month figure explicitly and footnotes that the headline reflects the 52-week prepaid option. The month-to-month figures bill every four weeks and the medication ships every four weeks, so a year is thirteen cycles, not twelve: $249 every four weeks is about $3,237 a year, or roughly $270 a month.

Compounded semaglutide (injection and oral tablet) and compounded tirzepatide, plus injectable and topical testosterone and enclomiphene on the hormone path. The site states plainly that compounded medications are not FDA-approved and that eligibility, labs, medication selection, prescribing and follow-up are determined by licensed clinicians. On the evidence: the GLP-1 outcome data belongs to the branded products, not compounded copies; testosterone replacement has real randomized data in symptomatic hypogonadism and requires ongoing lab monitoring; enclomiphene is not FDA-approved for raising testosterone and needs the same monitoring.